Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis
NCT04841512
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
COVID - Lack of recruitment
Conditions
Osteoarthritis, Spine
Interventions
BIOLOGICAL:
XT-150
Sponsor
Xalud Therapeutics, Inc.